Related Experiment Video
Updated: Jul 16, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections
Undurti N Das1,2,3,4
1UND Life Sciences, Battle Ground, WA, USA.
Abstract:
COVID-19 is caused by SARS-CoV-2 infection. Epithelial and T, NK, and other immunocytes release bioactive lipids especially arachidonic acid (AA) in response to microbial infections to inactivate them and upregulate the immune system. COVID-19 (coronavirus) and other enveloped viruses including severe acute respiratory syndrome (SARS-CoV-1 of 2002-2003) and Middle East respiratory syndrome (MERS; 2012-ongoing) and hepatitis B and C (HBV and HCV) can be inactivated by AA, γ-linolenic acid (GLA, dihomo-GLA (DGLA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), which are precursors to several eicosanoids. Prostaglandin E1, lipoxin A4, resolvins, protectins and maresins enhance phagocytosis of macrophages and leukocytes to clear debris from the site(s) of infection and injury, enhance microbial clearance and wound healing to restore homeostasis. Bioactive lipids modulate the generation of M1 and M2 macrophages and the activity of other immunocytes. Mesenchymal and adipose tissue-derived stem cells secrete LXA4 and other bioactive lipids to bring about their beneficial actions in COVID-19. Bioactive lipids regulate vasomotor tone, inflammation, thrombosis, immune response, inactivate enveloped viruses, regulate T cell proliferation and secretion of cytokines, stem cell survival, proliferation and differentiation, and leukocyte and macrophage functions, JAK kinase activity and neutrophil extracellular traps and thus, have a critical role in COVID-19.
Insights
Bioactive lipids like arachidonic acid (AA) inactivate enveloped viruses, including SARS-CoV-2. These lipids also enhance immune cell function and promote healing, playing a critical role in managing COVID-19 and restoring homeostasis.
Area of Science:
- Immunology
- Virology
- Lipidomics
Background:
- COVID-19, caused by SARS-CoV-2, involves immune responses and viral inactivation.
- Epithelial cells and immune cells release bioactive lipids, such as arachidonic acid (AA), during microbial infections.
- Enveloped viruses like SARS-CoV-2, SARS-CoV-1, MERS, HBV, and HCV can be inactivated by specific fatty acids.
Purpose of the Study:
- To elucidate the role of bioactive lipids in the immune response to SARS-CoV-2 infection.
- To highlight the antiviral and immunomodulatory functions of various fatty acids and their derivatives.
- To explore the therapeutic potential of bioactive lipids in managing COVID-19.
Main Methods:
- Review of scientific literature on bioactive lipids, viral inactivation, and immune responses.
- Analysis of the mechanisms by which fatty acids (AA, GLA, DGLA, EPA, DHA) and eicosanoids exert their effects.
- Examination of the role of mesenchymal stem cells and their secreted lipids in COVID-19.
Main Results:
- Bioactive lipids, including AA, GLA, DGLA, EPA, and DHA, can inactivate enveloped viruses.
- Eicosanoids derived from these lipids (e.g., Prostaglandin E1, lipoxin A4, resolvins) enhance phagocytosis and microbial clearance.
- Bioactive lipids modulate macrophage polarization (M1/M2), immune cell activity, and stem cell functions, crucial for COVID-19.
- These lipids regulate inflammation, thrombosis, immune responses, and vasomotor tone.
Conclusions:
- Bioactive lipids are critical in combating enveloped viral infections like COVID-19.
- Lipid mediators play multifaceted roles in immune regulation, tissue repair, and viral inactivation.
- Targeting bioactive lipid pathways presents a promising therapeutic strategy for COVID-19 and related conditions.
Related Concept Videos
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Biosynthesis of Lipids
Assembly of the Lipid Bilayer in the ER
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
Microorganisms in Medicine and Therapeutics
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

